Tower Research Capital LLC (TRC) - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$46,855
-89.7%
933
-87.0%
0.00%
-93.3%
Q2 2023$453,270
+444282.4%
7,172
+215.5%
0.02%
+400.0%
Q1 2023$102
+126.7%
2,273
+123.1%
0.00%
+50.0%
Q4 2022$45
-100.0%
1,019
-90.9%
0.00%
-83.3%
Q3 2022$737,000
-6.9%
11,193
-28.6%
0.01%
-33.3%
Q2 2022$792,000
+956.0%
15,679
+1245.8%
0.02%
+1700.0%
Q1 2022$75,000
-74.1%
1,165
-57.0%
0.00%
-80.0%
Q4 2021$290,000
+5.1%
2,708
+0.9%
0.01%
-28.6%
Q3 2021$276,000
+15.5%
2,684
-1.3%
0.01%
+16.7%
Q2 2021$239,000
-59.7%
2,718
-55.4%
0.01%
-40.0%
Q1 2021$593,000
+32.7%
6,093
+52.8%
0.01%
-28.6%
Q4 2020$447,000
-18.3%
3,987
-32.5%
0.01%
+133.3%
Q3 2020$547,000
+7.9%
5,909
-9.1%
0.01%
-71.4%
Q2 2020$507,000
+29.0%
6,497
+32.4%
0.02%
-36.4%
Q4 2019$393,000
+9725.0%
4,906
+8820.0%
0.03%
Q3 2019$4,000
+33.3%
55
+103.7%
0.00%
Q2 2019$3,000
+50.0%
27
+3.8%
0.00%
Q1 2019$2,000
-80.0%
26
-79.5%
0.00%
-100.0%
Q3 2018$10,000
+900.0%
127
+1487.5%
0.00%
Q2 2018$1,000
-99.5%
8
-99.7%
0.00%
-100.0%
Q4 2017$190,000
+1017.6%
2,513
+942.7%
0.02%
+2400.0%
Q3 2017$17,000
+325.0%
241
+52.5%
0.00%
Q4 2016$4,000
-85.7%
158
-89.7%
0.00%
-100.0%
Q1 2016$28,000
+250.0%
1,535
+334.8%
0.00%
+300.0%
Q3 2015$8,0003530.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders